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1. INTRODUCTION {#jcla22952-sec-0005}
===============

Colorectal cancer (CRC) is the third most widespread cancer in men and the second most widespread in women recently. Although screening diagnostic technique like colonoscopy and therapy involved in CRC has made great progress, CRC is fourth in mortality from cancer worldwide.[1](#jcla22952-bib-0001){ref-type="ref"} It is indispensable to find new early diagnostic biomarkers and explore the underlying molecular mechanism of CRC to improve detection rates for early CRC patients and reduced mortality in advanced CRC patients.

Circular RNA (circRNA) is a large number of endogenous RNA in eukaryote, which is a single‐stranded RNA that has a covalent closed loop with no 5′ and 3′ ends.[2](#jcla22952-bib-0002){ref-type="ref"} CircRNAs may arise from exons or introns of pre‐mRNA by back‐splicing.[3](#jcla22952-bib-0003){ref-type="ref"} Interestingly, they play distinctive roles in gene expression regulation and biological processes, participating in serving as microRNA (miRNA) sponge, transcription regulation, rolling circle translation, generating pseudogenes, and affecting alternative splicing.[4](#jcla22952-bib-0004){ref-type="ref"} Recent evidence suggested that circRNAs were closely related to human cancers including CRC mainly through acting as miRNA sponges that can bind with miRNAs to regulate their target genes which having similar miRNA response element (MRE).[3](#jcla22952-bib-0003){ref-type="ref"}, [5](#jcla22952-bib-0005){ref-type="ref"}, [6](#jcla22952-bib-0006){ref-type="ref"}

Up to date, RNA deep sequencing, which is gradually replacing in microarrays, has a greater dynamic range compared with microarrays.[7](#jcla22952-bib-0007){ref-type="ref"} In this study, we explored circRNAs in CRC based on RNA deep sequencing and screened differentially expressed circRNAs. Meanwhile, we analyzed the networks among mRNAs, miRNAs, and circRNAs. We performed gene ontology (GO) and pathway analyses of the differentially expressed circRNAs, especially identified them in CRC tissues correlated with Krüppel‐like factor 4 (KLF4), one of CRC‐associated transcription factors. Among them, we randomly selected hsa_circ_0142527 as a targeted circRNA to validate the expression levels in CRC tissues. Its gene is located at chr8_68038292_68022036 with a spliced length of 503 nt. Our results, for the first time, indicated that hsa_circ_0142527 may be served as a potential biomarker for the diagnosis of CRC.

2. MATERIALS AND METHODS {#jcla22952-sec-0006}
========================

2.1. Patients and specimens {#jcla22952-sec-0007}
---------------------------

All specimens were collected from two hospitals in different provinces in China. Forty‐one pairs of CRC tissues and their matched adjacent nontumorous tissues were obtained from surgical patients who were histologically confirmed to have CRC between 2016 and 2017 in the Center Gastroenterology of the Affiliated Hospital of Medical School of Ningbo University (China). The other 50 pairs were gathered from the Department of Abdominal Oncology of Zhejiang cancer hospital between 2010 and 2015. They had not got any therapies before received specimens. At the time of surgery, all tissue specimens were immediately preserved in RNA fixer (Bioteke, Beijing, China) at −80°C until use. Three of them were randomly selected for human RNA deep sequencing. Tumors were classified following the tumor‐node‐metastasis (TNM) staging system (7th ed.). Following the National Comprehensive Cancer Network (NCCN) Clinical Practice Guideline of Oncology (V.1.2012), histologic grade was evaluated. This project was approved by the Human Research Ethics Committee of Ningbo University. All participants received informed consent. Double‐blind manner was used through the overall process.

2.2. Library construction and RNA‐seq {#jcla22952-sec-0008}
-------------------------------------

Total RNA was extracted from three paired CRC and adjacent normal tissues using TRIzol (Ambion) according to the manufacturer\'s instructions and was quality controlled using Agilent 2200 (Agilent). Then, total RNA was used for library construction using TruSeq Stranded Total RNA with Ribo‐Zero Gold (Illumina). Following the manufacturer\'s instructions, strand‐specific RNA‐seq libraries were prepared. The libraries were quality controlled again with Agilent 2200 (Agilent) and sequenced using HiSeq X (Illumina).

2.3. RNA sequencing mapping and differentially expressed genes screen {#jcla22952-sec-0009}
---------------------------------------------------------------------

The processed clean reads were then aligned to human genome (version: hg19_GRCh37) using the MapSplice program (v2.1.6).

We filtered the differentially expressed genes using EBSeq algorithm[8](#jcla22952-bib-0008){ref-type="ref"} via the significant analysis including *P*‐value and false discovery rate (FDR) analysis under the following criteria: (a) fold change \>1.5 or \<0.667 and (b) FDR \<0.05.[9](#jcla22952-bib-0009){ref-type="ref"}

2.4. Go analysis {#jcla22952-sec-0010}
----------------

Gene ontology analysis was performed to facilitate elucidating the biological implications of unique genes in the significant or representative profiles of the differentially expressed gene in the experiment. We downloaded the GO annotations from NCBI (<http://www.ncbi.nlm.nih.gov/>), UniProt (<http://www.uniprot.org/>) and the GO (<http://www.geneontology.org/>). Fisher\'s exact test was applied to identify the significant GO categories, and FDR was used to correct the *P*‐values.

2.5. Pathway analysis {#jcla22952-sec-0011}
---------------------

Pathway analysis was used to find out the significant pathway of the differential genes according to Kyoto Encyclopedia of Genes and Genomes (KEGG) database (<https://www.kegg.jp/>). We turn to the Fisher\'s exact test to select the significant pathway, and the threshold of significance was defined by *P*‐value and FDR.[10](#jcla22952-bib-0010){ref-type="ref"}, [11](#jcla22952-bib-0011){ref-type="ref"}, [12](#jcla22952-bib-0012){ref-type="ref"}

2.6. Total RNA extraction, reverse transcription reaction, and qPCR {#jcla22952-sec-0012}
-------------------------------------------------------------------

Tissue RNA was extracted using TRIzol reagents (Ambion), following the manufacturer\'s instructions, respectively. The A260/A280 ratio in DS‐11 Spectrophotometer (DeNovix) and 1% agarose gel electrophoresis were then used to assess the quality of RNA. Finally, total RNA was reverse transcribed to cDNA by a GoScript Reverse Transcription (RT) System (Promega).

The real‐time quantitative reverse transcription polymerase chain reaction (qRT‐PCR) was performed using GoTaq qPCR Master Mix (Promega) on an Mx3005P Real‐Time PCR System (Stratagene) following the manufacturer\'s instructions. Divergent primers of hsa_circ_0142527, convergent primers of KLF4, and glyceraldehyde 3‐phosphate dehydrogenase (GAPDH, as a control) were designed and synthesized by Sangon Biotech. The sequences of hsa_circ_0142527, KLF4, and GAPDH were as follows: 5′‐GGGTCCAACATCACTGACACC‐3′ and 5′‐TGTGCCTTCTCATGGTTACTACAA‐3′ for hsa_circ_0142527; 5′‐CCTTCAACCTGGCGGACATCAAC‐3′ and 5′‐GCTGCTGCGGCGGAATGTAC‐3′ for KLF4; and 5′‐ACCCACTCCTCCACCTTTGAC‐3′ and 5′‐TGTTGCTGTAGCCAAATTCGTT‐3′ for GAPDH. The conditions of thermal cycling were as follows: 5 minutes at 95°C for a hot start; then 45 cycles at 94°C for 15 seconds, 54°C for 30 seconds, and 72°C for 30 seconds.[13](#jcla22952-bib-0013){ref-type="ref"} The cycle threshold (Ct) values of hsa_circ_0142527 and GAPDH were recorded. Targeted circRNA (hsa_circ_0142527) expression levels were calculated using the ΔCt method with GAPDH as the control.[14](#jcla22952-bib-0014){ref-type="ref"} Lower ΔCt values mean higher expression levels.

2.7. Cloning and sequencing of qRT‐PCR products {#jcla22952-sec-0013}
-----------------------------------------------

The qRT‐PCR products of hsa_circ_0142527 and KLF4 mRNA were purified using the UNIQ‐10 PCR Product Purification Kit (Sangon Biotech) and were cloned into the pUCm‐T vector (Sangon Biotech). Finally, PCR product sequencing was performed by the same company.[15](#jcla22952-bib-0015){ref-type="ref"}

2.8. Statistical analysis {#jcla22952-sec-0014}
-------------------------

All statistical analyses are based on Statistical Program for Social Sciences (SPSS) v18.0 (SPSS, lnc.) and GraphPad Prism 5.0 (GraphPad Software, lnc.). Student\'s *t* test, one‐way analysis of variance (ANOVA), and the rank‐sum test were used according to the actual conditions. The diagnostic value of hsa‐circ‐0142527 was evaluated by receiver operating characteristic (ROC) curve. *P*‐values \<0.05 were considered statistically significant.

3. RESULTS {#jcla22952-sec-0015}
==========

3.1. Overview of RNA deep sequencing of CRC tissues {#jcla22952-sec-0016}
---------------------------------------------------

Three patient samples were chosen from a CRC cohort. Histopathology was assessed by surgical histopathological examinations, and patient characteristics are shown in Table [S1](#jcla22952-sup-0001){ref-type="supplementary-material"}.

After clean reads mapping, a detailed statistical analysis was performed to understand the overview of RNA deep sequencing in CRC tissues (data accessible at NCBI GEO database, accession GSE121842, Zhang <https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE121842>). We found that the top three gene structures in transcriptome are exon, intron, and coding sequence (CDS) in CRC (Figure [1](#jcla22952-fig-0001){ref-type="fig"}A). Besides, we got reads distribution on all chromosomes (Figure [1](#jcla22952-fig-0001){ref-type="fig"}B).

![Overview of RNA deep sequencing in colorectal cancer (CRC) tissues. A, All gene structures in transcriptome. B, Chromosomes distribution of transcriptome reads in CRC tissues compared with human genome. C, Hierarchical cluster analysis showed several types of significantly differentially expressed RNAs including mRNAs, noncoding RNAs, and miscellaneous RNAs in CRC and paracancerous tissues. D, The volcano plot. The red dots in the plot represent RNA with statistical significance](JCLA-33-e22952-g001){#jcla22952-fig-0001}

Hierarchical clustering analysis showed the differential RNA expression levels between CRC and paracancerous tissues (Figure [1](#jcla22952-fig-0001){ref-type="fig"}C). A volcano plot (Figure [1](#jcla22952-fig-0001){ref-type="fig"}D) was constructed using fold change (FC) and false discovery rate (FDR) values to visualize the relationship between FC and statistical significance.[16](#jcla22952-bib-0016){ref-type="ref"}

3.2. Profiles of differentially expressed circRNAs in CRC {#jcla22952-sec-0017}
---------------------------------------------------------

After using EBSeq algorithm, a total of 4735 circRNAs were filtered (GSE121842). Among them, 67 differentially expressed circRNAs were revealed (FC \>2.0, FDR \<0.05). There are 36 upregulated and 31 downregulated circRNAs, respectively. Hierarchical clustering analysis revealed expression differences of circRNAs between CRC and paracancerous tissues (Figure [2](#jcla22952-fig-0002){ref-type="fig"}A). According to the log fold change, the top 10 upregulated and downregulated circRNAs in CRC tissue were selected (Table [1](#jcla22952-tbl-0001){ref-type="table"}, Figure [2](#jcla22952-fig-0002){ref-type="fig"}B). Among them, six circRNAs did not have circRNA ID in circBase (<http://www.circbase.org/>).

![Expression of circRNAs in colorectal cancer (CRC) tissues. A, Hierarchical cluster analysis of differentially expressed circRNAs in CRC and paracancerous tissues (FC \>2, FDR \<0.05). Significantly differentially expressed circRNAs between normal and malignant tissues of CRC are shown on a scale from green (low) to red (high). Individual tissues subsets are depicted as columns. B, The top 10 upregulated and downregulated circRNAs in CRC tissues](JCLA-33-e22952-g002){#jcla22952-fig-0002}

###### 

The top 10 upregulated and downregulated circRNAs in CRC tissues

  CircRNA ID                                               Chromosome   Regulation   Log^2^FC   FDR     Gene symbol   Strand   NO.   SeqLength
  -------------------------------------------------------- ------------ ------------ ---------- ------- ------------- -------- ----- -----------
  circIGHV3‐30‐1[a](#jcla22952-note-0001){ref-type="fn"}   chr14        Up           20.000     0.000   IGHV3‐30      −        1     288 233
  hsa_circ_0078617                                         chr6         Up           4.322      0.025   MAP3K4        \+       2     1555
  hsa_circ_0085558                                         chr8         Up           4.322      0.016   PVT1          \+       3     410
  hsa_circ_0003602                                         chr3         Up           4.229      0.008   SMARCC1       −        4     863
  hsa_circ_0071174                                         chr4         Up           3.907      0.034   LRBA          −        5     449
  hsa_circ_0067717                                         chr3         Up           3.672      0.026   RNF13         \+       6     425
  hsa_circ_0001615                                         chr6         Up           3.644      0.028   PHIP          −        7     411
  circAATF‐1[a](#jcla22952-note-0001){ref-type="fn"}       chr17        Up           3.570      0.005   AATF          \+       8     1022
  hsa_circ_0000724                                         chr16        Up           3.570      0.019   KLHDC4        −        9     407
  circMGAT5[a](#jcla22952-note-0001){ref-type="fn"}        chr2         Up           3.392      0.011   MGAT5         \+       10    17 456
  hsa_circ_0002220                                         chr17        Down         −3.557     0.005   MED13         −        10    503
  hsa_circ_0008287                                         chr19        Down         −3.913     0.007   GPATCH1       \+       9     304
  hsa_circ_0069865                                         chr4         Down         −4.068     0.000   LPHN3         \+       8     1702
  circVPS13‐1[a](#jcla22952-note-0001){ref-type="fn"}      chr8         Down         −4.115     0.004   VPS13B        \+       7     666
  hsa_circ_0067480                                         chr3         Down         −4.127     0.009   STAG1         −        6     637
  hsa_circ_0000038                                         chr1         Down         −4.577     0.005   PHACTR4       \+       5     783
  hsa_circ_0137008/hsa_circ_0142527                        chr8         Down         −4.667     0.000   PREX2         \+       4     503
  hsa_circ_0002578                                         chr15        Down         −4.667     0.022   PTPN9         −        3     321
  circIGHV3‐32‐1[a](#jcla22952-note-0001){ref-type="fn"}   chr14        Down         −20.000    0.000   IGHV3‐32      −        2     470 687
  circIGHV3‐20‐1[a](#jcla22952-note-0001){ref-type="fn"}   chr14        Down         −20.000    0.000   IGHV3‐20      −        1     382 044

No circRNA ID in circBase. We named them after their host gene.

John Wiley & Sons, Ltd

3.3. Gene ontology analysis and pathway analysis of differentially expressed circRNAs {#jcla22952-sec-0018}
-------------------------------------------------------------------------------------

Gene ontology analysis of the host genes which producing 67 differentially expressed circRNAs was performed to investigate the potential enriched GO. GO contains three domains: biological process (BP), molecular function (MF), and cellular components (CC).[17](#jcla22952-bib-0017){ref-type="ref"}

The enriched GO terms included 265 BPs, 141 MFs, and 93 CCs. According to the number of differential genes in a certain GO ID, the top 10 classifications of BPs, CCs, and MFs were shown (Figure [3](#jcla22952-fig-0003){ref-type="fig"}A). Among BPs, GO:0006351 (transcription, DNA‐templated) and GO:0006355 (regulation of transcription, DNA‐templated) were the most differential genes. Among MFs, GO:0005515 (protein binding) was the most differential gene. Among CCs, GO:0005634 (nucleus) was the most differential gene. According to the (−log~10~ *P* value), the top 15 BPs, MFs, and CCs were selected (Figure [3](#jcla22952-fig-0003){ref-type="fig"}B). The top five significant BPs were the regulation of cell morphogenesis, nucleosome disassembly, regulation of cell cycle, positive regulation of transcription, and DNA‐templated. According to the (−log~10~ *P* value) in MFs analysis, the top 15 were selected. The top five significant MFs were DNA replication origin binding, ubiquitin‐protein ligase activity, ligase activity, ubiquitin‐protein transferase activity, and beta‐mannosidase activity. According to the (−log~10~ *P* value), the top 15 CCs were selected. Origin recognition complex, nuclear origin of replication recognition complex, npBAF complex, nucleoplasm, and nBAF complex were top five significant CCs.

![Gene ontology (GO) analysis of the genes which producing 67 differentially expressed circRNAs. A, Top 10 classifications of biological processes (BPs), cellular components (CCs), and molecular functions (MFs) according to the number of linear counterparts of differentially expressed circRNAs. B, The top 15 significant BPs, MFs, and CCs according to the (−log~10~ *P* value) in GO analysis](JCLA-33-e22952-g003){#jcla22952-fig-0003}

To understand the function of differentially expressed circRNAs in CRC tissues, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis was performed. According to the enrichment score, the top two significant pathways were cell cycle and other glycan degradation (Figure [4](#jcla22952-fig-0004){ref-type="fig"}A). Interestingly, according to the (−log~10~ *P* value), the top two significant pathways also were cell cycle and other glycan degradation (Figure [4](#jcla22952-fig-0004){ref-type="fig"}B).

![Pathway analysis of the genes which producing 67 differentially expressed circRNAs. A, The arrangement of the host genes producing differentially expressed circRNAs according to the enrichment score. B, The arrangement of the host genes producing differentially expressed circRNAs according to the (−log~10~ *P* value)](JCLA-33-e22952-g004){#jcla22952-fig-0004}

3.4. Validation of the expression levels of KLF4 in CRC and identification of differentially expressed circRNAs correlate with KLF4 {#jcla22952-sec-0019}
-----------------------------------------------------------------------------------------------------------------------------------

Because one of circRNAs\' role is acting as miRNA sponges by binding with miRNAs, we predicted circRNAs which have the same binding sites with mRNAs. For example, 15 candidate circRNAs that are KLF4 competing endogenous RNAs (ceRNAs) in CRC tissues were selected (Figure [5](#jcla22952-fig-0005){ref-type="fig"}).

![circRNA/miRNA/KLF4 mRNA networks. KLF4 mRNA (pink circle) and 15 circRNAs (blue triangle) shared 16 miRNAs (green square)](JCLA-33-e22952-g005){#jcla22952-fig-0005}

Firstly, we verified KLF4 expression levels in paired CRC and paracancerous tissues in polycentricity. The results in both training group and confirm group showed that the expression levels of KLF4 in CRC tissues were significantly lower compared to those in paracancerous tissues (*P* \< 0.001, Figure [6](#jcla22952-fig-0006){ref-type="fig"}A). Then, hsa_circ_0142527 was randomly selected from 15 circRNAs which are KLF4 ceRNAs. The FC and FDR of hsa_circ_0142527 in RNA deep sequencing were −1. 821 and 0.0002, respectively. qRT‐PCR results in polycentricity indicated that hsa_circ_0142527 in CRC tissues was significantly lower compared to paracancerous tissues (*P* \< 0.001, Figure [6](#jcla22952-fig-0006){ref-type="fig"}B). The ROC curve was used for a comprehensive index reflecting the sensitivity and specificity of continuous variable.[18](#jcla22952-bib-0018){ref-type="ref"} The area under the curve (AUC) of hsa_circ_0142527 in training group was 0.818 (95% CI: 0.715‐0.920, *P* \< 0.001, Figure [6](#jcla22952-fig-0006){ref-type="fig"}D). The optimal cut‐off value of hsa_circ_0142527 was 14.625, with sensitivity and specificity 82.9% and 80.5%, respectively. The area under the curve (AUC) of hsa_circ_0142527 in confirm group was 0.942 (95% CI: 0.896‐0.987, *P* \< 0.001, Figure [6](#jcla22952-fig-0006){ref-type="fig"}D). The optimal cut‐off value of hsa_circ_0142527 was 6.72, with sensitivity and specificity 87.8% and 89.8%, respectively. The expression levels of hsa_circ_0142527 and clinicopathological features were also analyzed. We found that the expression levels of hsa_circ_0142527 were significantly associated with age (*P* = 0.004), differentiation (*P* = 0.008), invasion (*P* = 0.029), distal metastasis (*P* = 0.004), TNM stage (*P* = 0.005), and carcinoembryonic antigen (CEA; *P* = 0.037; Table [2](#jcla22952-tbl-0002){ref-type="table"}). Besides, we sequenced the qRT‐PCR products and confirmed the existence of KLF4 mRNA and hsa_circ_0142527 in CRC tissues (Figure [6](#jcla22952-fig-0006){ref-type="fig"}C). In addition, we found that KLF4 and hsa_circ_0142527 have high positive correlation (Figure [7](#jcla22952-fig-0007){ref-type="fig"}; *r* = 0.754, *P* \< 0.001).

![KLF4 mRNA and hsa_circ_0142527 expression levels in paired colorectal cancer (CRC) and paracancerous tissues in training and confirm groups. A, KLF4 expression levels in CRC and paracancerous tissues were detected by qRT‐PCR method. Training group (left): n = 39, \*\*\**P* \< 0.001. Confirm group (right): n = 49, \*\*\**P* \< 0.001. B, hsa_circ_0142527 expression levels in paired CRC and paracancerous tissues were detected by qRT‐PCR method. Training group (left): n = 41, \*\*\**P* \< 0.001. Confirm group (right): n = 49, \*\*\**P* \< 0.001. C, Sequencing results of KLF4 mRNA (top) and hsa_circ_0142527 (below) of qRT‐PCR products. D, The receiver operating characteristic (ROC) curves of hsa_circ_0142527 in polycentricity. Training group (left): the area under the curve (AUC) was 0.818 (95% CI: 0.715‐0.920, *P* \< 0.001). Confirm group (right): the AUC was 0.942 (95% CI: 0.896‐0.987, *P* \< 0.001)](JCLA-33-e22952-g006){#jcla22952-fig-0006}

###### 

The relationships between the expression levels of hsa_circ_0142527 and clinicopathological features of CRC patients

  Characteristics        No. of cases (%)   Mean ± SD        *P*‐value
  ---------------------- ------------------ ---------------- ------------------------------------------------
  Age (y)                                                    
  ≥55                    65 (72.2)          12.585 ± 4.284   0.004[\*](#jcla22952-note-0002){ref-type="fn"}
  \<55                   25 (27.8)          9.934 ± 3.549     
  Gender                                                     
  Male                   56 (62.2)          12.495 ± 4.236   0.063
  Female                 34 (37.8)          10.784 ± 4.101    
  Tumor location                                             
  Colon                  35 (38.9)          12.816 ± 4.347   0.085
  Rectum                 55 (61.1)          11.233 ± 4.100    
  Diameter (cm)                                              
  ≥5                     36 (40.0)          12.061 ± 4.407   0.701
  \<5                    54 (60.0)          11.707 ± 4.169    
  Differentiation                                            
  Well and moderate      77 (85.6)          11.660 ± 4.178   0.008[\*](#jcla22952-note-0002){ref-type="fn"}
  Poor                   13 (14.4)          8.014 ± 1.940     
  Invasion                                                   
  T1 & T2 & T3           32 (35.6)          13.176 ± 4.105   0.029[\*](#jcla22952-note-0002){ref-type="fn"}
  T4                     58 (64.4)          11.117 ± 4.211    
  Lymphatic metastasis                                       
  N0                     44 (48.9)          12.444 ± 4.376   0.185
  N1‐2                   46 (51.2)          11.239 ± 4.119    
  Distal metastasis                                          
  M0                     65 (72.2)          12.627 ± 3.905   0.004[\*](#jcla22952-note-0002){ref-type="fn"}
  M1                     25 (27.8)          9.824 ± 4.499     
  TNM stage                                                  
  I & II & III           64 (71.1)          12.620 ± 3.936   0.005[\*](#jcla22952-note-0002){ref-type="fn"}
  IV                     26 (28.9)          9.824 ± 4.499     
  CA19‐9                                                     
  Positive               15 (16.7)          10.667 ± 4.433   0.241
  Negative               75 (83.3)          12.124 ± 4.201    
  CEA                                                        
  Positive               29 (32.2)          10.550 ± 4.511   0.037[\*](#jcla22952-note-0002){ref-type="fn"}
  Negative               61 (67.8)          12.545 ± 3.989    

*P* \< 0.05.

John Wiley & Sons, Ltd

![KLF4 and hsa_circ_0142527 have high positive correlation. (*r* = 0.754, *r* ^2^ = 0.568，*P* \< 0.001)](JCLA-33-e22952-g007){#jcla22952-fig-0007}

4. DISCUSSION {#jcla22952-sec-0020}
=============

CircRNAs are a large class of endogenous RNAs in eukaryote. Because of the properties of abundant, stable, diverse, and conserved, circRNAs are involved in various diseases.[19](#jcla22952-bib-0019){ref-type="ref"} Bachmayr‐Heyda et al[20](#jcla22952-bib-0020){ref-type="ref"} firstly reported that a global reduction of circular RNA abundance in CRC cell lines and cancer tissues showed a negative correlation of global circular RNA abundance and proliferation. Zeng et al[12](#jcla22952-bib-0012){ref-type="ref"} showed that CircHIPK3 promoted CRC growth and metastasis by sponging miR‐7. Zeng et al[21](#jcla22952-bib-0021){ref-type="ref"} detected 431 differentially expressed circRNAs from CRC tissues of patients with lung metastasis and constructed circRNA/miRNA interactions, They demonstrated that hsa_circ_102761, hsa_circ_086376, and hsa_circ_105055 bonded with miR‐7 and regulated target genes *EPHA3*, *PRKCB*, *BRCA1*, and *ABCC1* in CRC with lung metastasis.[21](#jcla22952-bib-0021){ref-type="ref"} Besides, Zhang et al[22](#jcla22952-bib-0022){ref-type="ref"} demonstrated that hsa_circ_0020397 regulated CRC cell viability, invasion, and apoptosis by promoting the expression of miR‐138 targets *TERT* and *PD‐L1*. Xie et al[23](#jcla22952-bib-0023){ref-type="ref"} revealed the regulatory mechanism of hsa_circ_001569/miR‐145/*E2F5*, *BAG4*, *FMNL2* axis in cell proliferation and invasion in CRC.

In this study, we performed a human RNA deep sequencing to explore the circRNAs expression profiles in CRC (Figure [1](#jcla22952-fig-0001){ref-type="fig"}). We found 67 differentially expressed circRNAs, 36 upregulated and 31 downregulated circRNAs, respectively (Figure [2](#jcla22952-fig-0002){ref-type="fig"}). Among the top 10 upregulated and downregulated circRNAs in CRC, six circRNAs had no circRNA ID in circBase (Table [1](#jcla22952-tbl-0001){ref-type="table"}). These circRNAs may be new circRNAs. Besides, all the top 10 upregulated and 10 downregulated circRNAs were not found in CRC cancer tissues before October 24, 2018, in the literatures from PubMed (<https://www.ncbi.nlm.nih.gov/pubmed/>). These results provide new information for further understanding the occurrence of CRC.

One major mechanism of circRNAs is acting as miRNAs to regulate gene expression. It is now well established that KLF4 (also called gut‐enriched Krüppel‐like factor or GKL)[24](#jcla22952-bib-0024){ref-type="ref"} is a key suppressor gene in CRC involved in multiple key CRC pathways such as Notch pathway and Wnt/β‐catenin pathway.[25](#jcla22952-bib-0025){ref-type="ref"}, [26](#jcla22952-bib-0026){ref-type="ref"}, [27](#jcla22952-bib-0027){ref-type="ref"}, [28](#jcla22952-bib-0028){ref-type="ref"}, [29](#jcla22952-bib-0029){ref-type="ref"} A number of miRNAs can bind to the 3′‐untranslated region (3′‐UTR) of KLF4 mRNA.[25](#jcla22952-bib-0025){ref-type="ref"}, [26](#jcla22952-bib-0026){ref-type="ref"}, [27](#jcla22952-bib-0027){ref-type="ref"}, [30](#jcla22952-bib-0030){ref-type="ref"}, [31](#jcla22952-bib-0031){ref-type="ref"}, [32](#jcla22952-bib-0032){ref-type="ref"}, [33](#jcla22952-bib-0033){ref-type="ref"}, [34](#jcla22952-bib-0034){ref-type="ref"} Hence, we predicted 15 candidate circRNAs as KLF4 ceRNA in CRC tissues (Figure [5](#jcla22952-fig-0005){ref-type="fig"}). Hsa_circ_0142527 was selected as a targeted circRNA to validate the accuracy of RNA deep sequencing. Our results showed that hsa_circ_0142527 in CRC was significantly lower compared to matched paracancerous tissues (Figure [6](#jcla22952-fig-0006){ref-type="fig"}). The area under the ROC curves was 0.702 (Figure [6](#jcla22952-fig-0006){ref-type="fig"}D). More importantly, the expression levels of hsa_circ_0142527 were significantly associated with age, differentiation, invasion, distal metastasis, TNM stage, and carcinoembryonic antigen (CEA; Table [2](#jcla22952-tbl-0002){ref-type="table"}). The moderate correlations between KLF4 and hsa_circ_0142527 were documented (Figure [7](#jcla22952-fig-0007){ref-type="fig"}).

Nowadays, whether circRNAs can regulate host genes is controversial. Du et al[35](#jcla22952-bib-0035){ref-type="ref"} found that over‐expressed circ‐DNMT1 increased the mRNA level of the parent gene *DNMT1*. A recent study indicated that circITGA7 inhibited CRC growth and metastasis by modulating Ras pathway and upregulating transcription of its host gene *ITGA7*.[36](#jcla22952-bib-0036){ref-type="ref"} Besides, circEIF3J and circPAIP2 showed interactions with RNA Pol II, U1 snRNP, and parental gene promoters to promote the transcription of host genes.[37](#jcla22952-bib-0037){ref-type="ref"} These results indicate that some circRNAs can regulate their host genes.

Furthermore, we performed GO analysis of the host genes producing the differentially expressed circRNAs. The top five significant BPs were regulation of cell morphogenesis, nucleosome disassembly, regulation of cell cycle, positive regulation of transcription, and DNA‐templated (Figure [3](#jcla22952-fig-0003){ref-type="fig"}). It was required for transcription controls that underlie differentiation, development, and tumor suppression.[38](#jcla22952-bib-0038){ref-type="ref"} Another previous study also revealed apoptosis‐antagonizing transcription factor (*AATF*), one number of differentially expressed circRNA circAATF‐1, was involved in transcriptional regulation, cell cycle control, DNA damage responses, and in the execution of cell death programs.[39](#jcla22952-bib-0039){ref-type="ref"} GO analysis showed that the occurrence and progress of CRC were co‐regulated by differentially expressed circRNAs from different functional systems (Figure [3](#jcla22952-fig-0003){ref-type="fig"}). Moreover, according to the enrichment score or (−log~10~ *P* value), the top 2 pathways were cell cycle and other glycan degradation (Figure [4](#jcla22952-fig-0004){ref-type="fig"}). In our study, three differentially expressed circRNAs (ORC4, STAG1, and ORC2) were predicted involved in cell cycle.

In conclusion, our study provided a circRNA expression profiles in CRC and established a network among miRNAs, mRNAs, and circRNAs in CRC. We also firstly demonstrated that hsa_circ_0142527 may be a potential new biomarker for the diagnosis of CRC.
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